Management of uncontrolled type 2 diabetes in patients taking basal insulin - QI&CPD - Category 2

Duration

2 hrs

Profession

Physician

# of Credits

4.0

Accreditation

QI & CPD - Category 2

Expiry Date

2020-11-01

Diabetes is a national health priority, having a significant impact on the health and wellbeing of the Australian population. An estimated 1.7 million Australians have diabetes, with type 2 diabetes (T2D) accounting for 85% of all diabetes. Data from the Australian Institute of Health and Welfare (AIHW) indicates that diabetes was the underlying cause of 3% of all deaths and an underlying or associated cause of 10% of all deaths in 2011. The AusDiab study, the first longitudinal population-based study to examine the epidemiology of diabetes and its complications, found that over 12 years, people with known diabetes had an almost five-times higher mortality rate than those with normal glucose tolerance.

This activity has been approved by The Royal Australian College of General Practitioners QI&CPD Program. Total Points: 4.00 Point(s) (Category 2)

Damian Flanagan
MBBS, MWell, DipRACOG
South Coast Medical
Blairgowrie, Victoria, Australia

Ivan Kuo
MBBS, FRACP
Endocrinologist, Campbelltown and Napean Hospitals
Sydney, NSW, Australia

On completion of this program, participants will be better able to:

  1. Review the barriers to initiation of insulin and titration of insulin doses
  2. Identify patients who might benefit from switching insulin to reduce the risk of hypoglycaemic episodes
  3. Implement simple dose titration strategies with patients to attain a maintenance dose that will facilitate good glycaemic control while minimising hypoglycaemic episodes
  4. Identify patients who would benefit from referral to an endocrinologist


Related Courses